Gamco Investors INC. ET AL Sells 1,377 Shares of Chemed Corporation $CHE

Key Points

• Gamco Investors INC. ET AL has reduced its position in Chemed Corporation by 6.5%, holding approximately 19,907 shares valued at $12.25 million as of the latest SEC filing.
• Chemed reported Q2 earnings of $4.27 per share, falling short of analysts' expectations of $6.02, while also experiencing total revenue of $618.80 million compared to anticipated revenue of $650.60 million.
• The company recently declared a quarterly dividend increase to $0.60 per share, up from the previous $0.50, reflecting a commitment to returning value to shareholders.

Gamco Investors INC. ET AL decreased its position in Chemed Corporation (NYSE:CHE - Free Report) by 6.5% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 19,907 shares of the company's stock after selling 1,377 shares during the period. Gamco Investors INC. ET AL owned about 0.14% of Chemed worth $12,249,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Alpine Bank Wealth Management acquired a new position in Chemed in the 1st quarter valued at approximately $29,000. HM Payson & Co. acquired a new position in shares of Chemed in the 1st quarter worth approximately $30,000. SVB Wealth LLC acquired a new position in shares of Chemed in the 1st quarter worth approximately $30,000. Whipplewood Advisors LLC raised its holdings in shares of Chemed by 54.5% in the 1st quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock worth $31,000 after buying an additional 18 shares in the last quarter. Finally, Versant Capital Management Inc raised its holdings in shares of Chemed by 600.0% in the 1st quarter. Versant Capital Management Inc now owns 98 shares of the company's stock worth $60,000 after buying an additional 84 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Insiders Place Their Bets

In other Chemed news, EVP Nicholas Michael Westfall sold 10,012 shares of the stock in a transaction on Monday, August 4th. The stock was sold at an average price of $421.91, for a total value of $4,224,162.92. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director George J. Walsh III acquired 200 shares of the firm's stock in a transaction on Monday, August 4th. The stock was purchased at an average price of $417.10 per share, for a total transaction of $83,420.00. Following the completion of the transaction, the director directly owned 3,523 shares in the company, valued at approximately $1,469,443.30. The trade was a 6.02% increase in their position. The disclosure for this purchase can be found here. 3.29% of the stock is currently owned by company insiders.

Chemed Trading Up 1.5%

NYSE CHE traded up $6.72 during trading hours on Friday, reaching $458.62. 154,376 shares of the company's stock were exchanged, compared to its average volume of 172,316. The stock has a market cap of $6.68 billion, a PE ratio of 23.58, a price-to-earnings-growth ratio of 2.52 and a beta of 0.46. Chemed Corporation has a one year low of $408.42 and a one year high of $623.60. The firm has a fifty day moving average of $463.24 and a 200-day moving average of $537.34.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $4.27 EPS for the quarter, missing analysts' consensus estimates of $6.02 by ($1.75). The firm had revenue of $618.80 million during the quarter, compared to the consensus estimate of $650.60 million. Chemed had a net margin of 11.56% and a return on equity of 25.83%. The firm's quarterly revenue was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $5.47 earnings per share. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. As a group, research analysts forecast that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 11th were given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date was Monday, August 11th. This is a positive change from Chemed's previous quarterly dividend of $0.50. Chemed's dividend payout ratio is 12.34%.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Jefferies Financial Group assumed coverage on Chemed in a report on Friday, July 25th. They issued a "hold" rating and a $500.00 target price for the company. Oppenheimer dropped their target price on Chemed from $650.00 to $580.00 and set an "outperform" rating for the company in a report on Thursday, July 31st. Bank of America dropped their target price on Chemed from $708.00 to $650.00 and set a "buy" rating for the company in a report on Monday, June 30th. Royal Bank Of Canada dropped their target price on Chemed from $640.00 to $589.00 and set an "outperform" rating for the company in a report on Thursday, July 31st. Finally, Wall Street Zen lowered Chemed from a "buy" rating to a "hold" rating in a research report on Saturday, July 5th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $579.75.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.